Wilms' tumor Recruiting Phase 2 Trials for LY-3023414 (DB12167)

Also known as: Wilms Tumour / Wilms Tumor / Wilm's Tumor / Wilm's tumour / Nephroma / Nephroblastoma

IndicationStatusPhase
DBCOND0021654 (Wilms' tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03155620Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Screening
NCT03213678PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Treatment